DE69715247D1 - Auf quinupristin und dalfopristin basierte stabilisierte pharmazeutische zusammensetzung, und deren zubereitung - Google Patents

Auf quinupristin und dalfopristin basierte stabilisierte pharmazeutische zusammensetzung, und deren zubereitung

Info

Publication number
DE69715247D1
DE69715247D1 DE69715247T DE69715247T DE69715247D1 DE 69715247 D1 DE69715247 D1 DE 69715247D1 DE 69715247 T DE69715247 T DE 69715247T DE 69715247 T DE69715247 T DE 69715247T DE 69715247 D1 DE69715247 D1 DE 69715247D1
Authority
DE
Germany
Prior art keywords
dalfopristin
quinupristin
preparation
pharmaceutical composition
stabilized pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69715247T
Other languages
English (en)
Other versions
DE69715247T2 (de
Inventor
Jean-Paul Bounine
Guillaume Conrath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monarch Pharmaceuticals Ireland Ltd
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE69715247D1 publication Critical patent/DE69715247D1/de
Application granted granted Critical
Publication of DE69715247T2 publication Critical patent/DE69715247T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69715247T 1996-11-19 1997-11-14 Auf quinupristin und dalfopristin basierte stabilisierte pharmazeutische zusammensetzung, und deren zubereitung Expired - Lifetime DE69715247T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614062A FR2755857B1 (fr) 1996-11-19 1996-11-19 Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
PCT/FR1997/002047 WO1998022107A1 (fr) 1996-11-19 1997-11-14 Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation

Publications (2)

Publication Number Publication Date
DE69715247D1 true DE69715247D1 (de) 2002-10-10
DE69715247T2 DE69715247T2 (de) 2003-04-30

Family

ID=9497744

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69715247T Expired - Lifetime DE69715247T2 (de) 1996-11-19 1997-11-14 Auf quinupristin und dalfopristin basierte stabilisierte pharmazeutische zusammensetzung, und deren zubereitung

Country Status (45)

Country Link
US (1) US5994338A (de)
EP (1) EP0949923B1 (de)
JP (1) JP4278115B2 (de)
KR (1) KR100530836B1 (de)
CN (1) CN1146417C (de)
AP (1) AP998A (de)
AR (1) AR008695A1 (de)
AT (1) ATE223217T1 (de)
AU (1) AU740291B2 (de)
BG (1) BG63621B1 (de)
BR (1) BR9713087A (de)
CA (1) CA2271095C (de)
CO (1) CO4910113A1 (de)
CZ (1) CZ299913B6 (de)
DE (1) DE69715247T2 (de)
DK (1) DK0949923T3 (de)
DZ (1) DZ2349A1 (de)
EA (1) EA002025B1 (de)
EE (1) EE03668B1 (de)
ES (1) ES2179375T3 (de)
FR (1) FR2755857B1 (de)
HK (1) HK1022832A1 (de)
HR (1) HRP970615B1 (de)
HU (1) HUP9904327A3 (de)
IL (2) IL129607A0 (de)
IN (1) IN187038B (de)
JO (1) JO1992B1 (de)
MA (1) MA26448A1 (de)
MY (1) MY123805A (de)
NO (1) NO992399D0 (de)
NZ (1) NZ334949A (de)
OA (1) OA11047A (de)
PE (1) PE13999A1 (de)
PL (1) PL190164B1 (de)
PT (1) PT949923E (de)
RS (1) RS49608B (de)
SA (1) SA97180645B1 (de)
SK (1) SK284311B6 (de)
TN (1) TNSN97184A1 (de)
TR (1) TR199901096T2 (de)
TW (1) TW474816B (de)
UA (1) UA59376C2 (de)
UY (1) UY24780A1 (de)
WO (1) WO1998022107A1 (de)
ZA (1) ZA9710435B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772272B1 (fr) * 1997-12-16 2000-01-14 Rhone Poulenc Rorer Sa Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
EP1674107B8 (de) * 1998-09-25 2017-01-25 Cubist Pharmaceuticals LLC Verwendung von Daptomycin
KR100613136B1 (ko) * 1999-03-03 2006-08-17 일라이 릴리 앤드 캄파니 미셀-형성 계면활성제를 함유하는 에키노칸딘 제약학적조제물
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
US6119269A (en) * 1999-09-23 2000-09-19 Imler; Jack Fishing vest with removable storage container system
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
FR2812549B1 (fr) * 2000-08-03 2003-03-21 Aventis Pharma Sa Associations dalfopristine/quinupristine avec le cefpirome
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549065B1 (fr) * 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2576022B1 (fr) * 1985-01-11 1987-09-11 Rhone Poulenc Sante Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2599036B1 (fr) * 1986-05-22 1988-09-09 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CO4910113A1 (es) 2000-04-24
FR2755857A1 (fr) 1998-05-22
JP4278115B2 (ja) 2009-06-10
MA26448A1 (fr) 2004-12-20
IL129607A0 (en) 2000-02-29
TNSN97184A1 (fr) 2005-03-15
HUP9904327A3 (en) 2002-03-28
UY24780A1 (es) 2001-08-27
SK284311B6 (sk) 2005-01-03
WO1998022107A1 (fr) 1998-05-28
EP0949923B1 (de) 2002-09-04
BG103412A (en) 2000-06-30
AU5125698A (en) 1998-06-10
NO992399L (no) 1999-05-19
OA11047A (fr) 2003-03-07
SK66099A3 (en) 2000-01-18
FR2755857B1 (fr) 1998-12-24
PT949923E (pt) 2003-01-31
SA97180645B1 (ar) 2005-12-12
UA59376C2 (uk) 2003-09-15
CZ299913B6 (cs) 2008-12-29
CN1233959A (zh) 1999-11-03
HK1022832A1 (en) 2000-08-25
EA002025B1 (ru) 2001-12-24
RS49608B (sr) 2007-06-04
PL190164B1 (pl) 2005-11-30
DK0949923T3 (da) 2002-12-23
ATE223217T1 (de) 2002-09-15
TR199901096T2 (xx) 1999-07-21
ZA9710435B (en) 1998-06-10
ES2179375T3 (es) 2003-01-16
AR008695A1 (es) 2000-02-09
EE9900127A (et) 1999-12-15
NO992399D0 (no) 1999-05-19
BG63621B1 (bg) 2002-07-31
HRP970615A2 (en) 1998-08-31
CZ174899A3 (cs) 1999-08-11
JP2001504475A (ja) 2001-04-03
YU22499A (sh) 2002-03-18
AP998A (en) 2001-08-09
PE13999A1 (es) 1999-05-05
US5994338A (en) 1999-11-30
EA199900479A1 (ru) 2000-02-28
DE69715247T2 (de) 2003-04-30
CN1146417C (zh) 2004-04-21
IN187038B (de) 2001-12-29
IL129607A (en) 2006-08-20
CA2271095A1 (fr) 1998-05-28
KR100530836B1 (ko) 2005-11-23
DZ2349A1 (fr) 2002-12-28
BR9713087A (pt) 2000-03-28
CA2271095C (fr) 2004-08-03
KR20000053343A (ko) 2000-08-25
AU740291B2 (en) 2001-11-01
TW474816B (en) 2002-02-01
EE03668B1 (et) 2002-04-15
EP0949923A1 (de) 1999-10-20
JO1992B1 (en) 1999-05-15
HUP9904327A2 (hu) 2000-06-28
NZ334949A (en) 2000-12-22
HRP970615B1 (en) 2002-12-31
MY123805A (en) 2006-06-30

Similar Documents

Publication Publication Date Title
DE69606028T2 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
ATE250593T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE69525148T2 (de) Pharmazeutische formulierung
DE69840552D1 (de) Verbindungen und Pharmazeutische Zusammensetzungen mit appetitunterdrückender Aktivität
HUP9601566A2 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
ATE248584T1 (de) Neues arzneimittel mit anästhetischer wirkung
DE69807420D1 (de) Pharmazeutische aerosolzusammensetzung
DE69300913T2 (de) Polymorph Terazosin und pharmazeutische Zusammenstellung.
DE69828895D1 (de) Alpha-aryl-n-alkylnitrone sowie diese enthaltende pharmazeutische zubereitungen
DE69524592D1 (de) 2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung
DE69608680D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE69519368D1 (de) Neue antiandrogenen mitteln pharmazeutische präparate und verwendungen davon
DE4294862T1 (de) Pharmazeutische Komposition
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
DE69706146T2 (de) Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69715247D1 (de) Auf quinupristin und dalfopristin basierte stabilisierte pharmazeutische zusammensetzung, und deren zubereitung
ATE195940T1 (de) Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE69415570D1 (de) Esculetin Derivate und pharmazeutische Zusammenstellung
BR9607433A (pt) Composição farmacêutica para administração parental
DE69725166D1 (de) Substituierte benzamidderivate und diese enthaltende pharmazeutische zusammensetzung
DE19681529D2 (de) Pharmazeutische Darreichungsform
DE69509621T2 (de) Diarylheptanoidderivat und diese enthaltende pharmazeutische Zusammensetzung
DE69703716T2 (de) Aromatische Verbindung und seine pharmazeutische Zusammensetzung
ATA77096A (de) Pharmazeutische präparation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MONARCH PHARMACEUTICALS IRELAND LTD., BALLSBRIDGE,

8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC